Taken together, our findings indicated that p53 loss and p53 mutation in pancreatic cancer cells differentially affect the subclusters of various cell populations such as endothelial cell, CAFs, and immune cells. This evidence concerns the gene TP53 and familial pancreatic carcinoma.